Commercial Health Plan and Enrollee Out-of-Pocket Spending on Accelerated Approval Products in 2019.
作者信息
Jazowski Shelley A, Vaidya Avi U, Donohue Julie M, Dusetzina Stacie B, Sachs Rachel E
机构信息
Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania.
出版信息
JAMA Intern Med. 2023 Sep 1;183(9):1016-1018. doi: 10.1001/jamainternmed.2023.2381.
Abstract
摘要
相似文献
1
Commercial Health Plan and Enrollee Out-of-Pocket Spending on Accelerated Approval Products in 2019.2019年商业健康保险计划及参保人在加速批准产品上的自付费用
JAMA Intern Med. 2023 Sep 1;183(9):1016-1018. doi: 10.1001/jamainternmed.2023.2381.
2
Oregon's Hospital Payment Cap and Enrollee Out-of-Pocket Spending and Service Use.俄勒冈州的医院支付上限和参保者自付支出及服务使用情况。
JAMA Health Forum. 2024 Aug 2;5(8):e242614. doi: 10.1001/jamahealthforum.2024.2614.
3
Financial Risk for COVID-19-like Respiratory Hospitalizations in Consumer-Directed Health Plans.消费者导向型健康计划中类似 COVID-19 的呼吸道住院的财务风险。
Am J Prev Med. 2020 Sep;59(3):445-448. doi: 10.1016/j.amepre.2020.05.008. Epub 2020 Jun 15.
4
The effect of incentive-based formularies on prescription-drug utilization and spending.基于激励措施的药品处方集对处方药使用及支出的影响。
N Engl J Med. 2003 Dec 4;349(23):2224-32. doi: 10.1056/NEJMsa030954.
5
Employer drug benefit plans and spending on prescription drugs.雇主药物福利计划与处方药支出
JAMA. 2002 Oct 9;288(14):1733-9. doi: 10.1001/jama.288.14.1733.
6
Out-Of-Pocket Spending For Maternity Care Among Women With Employer-Based Insurance, 2008-15.2008-2015 年，有雇主保险的女性生育护理自付支出。
Health Aff (Millwood). 2020 Jan;39(1):18-23. doi: 10.1377/hlthaff.2019.00296.
7
The Association of Out-of-Pocket Spending and Health Status With Consumer-Directed Health Plan Choice.自付费用支出与健康状况与消费者导向型健康计划选择的关联。
J Healthc Manag. 2018 Jul-Aug;63(4):e60-e74. doi: 10.1097/JHM-D-16-00039.
8
Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.三层药品目录对儿童注意力缺陷多动障碍药物治疗的影响。
Arch Gen Psychiatry. 2005 Apr;62(4):435-41. doi: 10.1001/archpsyc.62.4.435.
9
Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.州平价法实施后口服抗癌治疗患者自付费用和医疗支出变化。
JAMA Oncol. 2018 Jun 14;4(6):e173598. doi: 10.1001/jamaoncol.2017.3598.
10
Plan Selection, Enrollee Risk, and Health Spending on the Patient Protection and Affordable Care Act Individual Marketplaces, 2019.《2019 年患者保护与平价医疗法案个人市场的计划选择、参保人风险与医疗支出》
JAMA Netw Open. 2023 Mar 1;6(3):e234529. doi: 10.1001/jamanetworkopen.2023.4529.
引用本文的文献
1
The high costs of anticancer therapies in the USA: challenges, opportunities and progress.美国抗癌疗法的高昂成本：挑战、机遇和进展。
Nat Rev Clin Oncol. 2024 Dec;21(12):888-899. doi: 10.1038/s41571-024-00948-1. Epub 2024 Oct 4.
Zotero 插件